SAN DIEGO– Illumina, Inc. (NASDAQ: ILMN) announced today that Caroline Dorsa has joined the company’s Board of Directors. Given her financial expertise, Ms. Dorsa will also participate on the Audit Committee of the Board. Ms. Dorsa has held a number of senior management positions at Merck & Co., Inc., including Senior Vice President of Marketing Strategy […]
Boston, US, Durham, US & London, UK – Precision BioSciences, a genome editing company based in Durham, North Carolina, has implemented IDBS E‑WorkBook to improve its data capture and streamline innovation in cancer immunotherapy, gene therapy and food science. Deploying E‑WorkBook across its three businesses will improve Precision BioSciences’ knowledge sharing and collaboration. Paul Denny-Gouldson, Vice […]
PathogenDx, an Arizona-based biotechnology company, has developed a disruptive testing technology for pathogen detection for the botanical, food, and Ag testing markets. The company entered into a national sales and distribution agreement with Emerald Scientific to supply it PDx-C Ultra-Rapid kit that can detect pathogens in less than 6 hours to testing labs focused on […]
BRISBANE, Calif. — CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value diagnostic solutions for transplant recipients, announces that it has signed an agreement with Illumina, Inc. (Nasdaq:ILMN) for the acquisition of Conexio SBT Resolver™ products and Assign™ SBT analysis software for high resolution HLA typing. SBT Resolver assay designs […]
The In-Fusion Cloning Primer Design Tool, powered by TeselaGen, generates primer sequences and vector maps Mountain View and San Francisco, CA—Takara Bio USA, Inc. (TBUSA, formerly Clontech Laboratories, Inc.), a wholly owned subsidiary of Takara Bio Inc., today announced the launch of the In-Fusion Cloning Primer Design Tool, powered by TeselaGen Biotechnology, Inc. software. In-Fusion […]
U.S. Patent and Trademark Office finds U.S. Patent No. 8,658,430 invalid in inter partes review PLEASANTON, Calif. – 10x Genomics, Inc. today announced that the company has prevailed in an inter partes review proceeding before the U.S. Patent and Trademark Office to invalidate U.S. Patent No. 8,658,430 owned by RainDance Technologies, Inc. 10x initiated the proceeding after […]
Acquisition brings unprecedented scale and speed to organism design BOSTON — Ginkgo Bioworks, the organism company, announced today the acquisition of Gen9, a pioneer in the synthesis and assembly of DNA. The acquisition will bring Gen9’s unique expertise in assembling pathway-length synthetic DNA into Ginkgo’s automated organism engineering foundries, enabling improved speed and capacity in the […]
New Two-Year Agreement with Belgian University to Focus on Detecting Genetic Abnormalities in Cell-free DNA and Embryo Biopsies SANTA CLARA, Calif. Agilent Technologies Inc. (NYSE: A) today announced that it is extending its collaboration with the Centre for Human Genetics of the University of Leuven and the University Hospital of Leuven in Belgium. Joris Vermeesch, […]
Mountain View, CA—Takara Bio USA Holdings, Inc. (“TBUSH”) announced that it has completed the acquisition of Rubicon Genomics, Inc. (“Rubicon”), Rubicon has become a wholly-owned subsidiary of TBUSH as of January 17, 2017 (US local time). The Takara Bio Group provides a wide range of life science products and services under the Takara, Clontech, and […]
Renewal continues fundamental research into advanced biofuels Large team of researchers focused on Synthetic Genomics’ core synthetic biology technologies Progress continues toward development of algae-based transportation fuels LA JOLLA, Calif.—-Synthetic Genomics, Inc. and ExxonMobil (NYSE: XOM) announced today that they have extended their agreement to conduct joint research into advanced algae biofuels after making significant […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
